Letter from the Editor

Dear Reader,Dear Colleagues,

The 4th annual Congress of the European Academy of Neurology was held in Lisbon on June 16th – 19th this year. The scientific programme featured top speakers, stimulating discussions, and news on scientific breakthroughs. More than 6,700 participants from 104 countries attended the meeting. It covered the whole range of neurologic disorders in various formats, and offered altogether 42 scientific and 48 educational sessions. More than 2,100 abstracts had been submitted and discussed. The overarching theme of the Lisbon conference was: “Molecular and genetic therapies for neurogenetic disorders” with state of the art lectures on e.g. spinal muscular atrophy and familial amyloidosis.The conference built on the enormous success of the previous editions and continues to be Europe’s foremost forum for discussing and disseminating the latest standards, guidelines, and updates on neurology management and care. During the Late Breaking News session two papers were simultaneously released online by Lancet Neurology. One paper reported on the effects of cognitive behavioural therapy of severely fatigued patients with myotonic dystrophy type 1, while the other study reported the results of a trial on the safety and efficacy of rasagiline as an add-on therapy in patients with ALS.This conference report summarises the main topics of the Lisbon conference. Enjoy reading.Best regards,Valeria Caso

Prof. Valeria Caso

Biography
Valeria Caso is a stroke neurologist at the University of Perugia Stroke Unit, Italy and has been recently certified in the role of full professor in Neurology.She is past president of the European Stroke Organisation (ESO) and member of the EAN Programme Committee. She has authored and co-authored more than 200 published papers and book-chapters.She has been involved in 20 multicentre trials serving in various positions including steering committees. She is currently actively involved in international research projects on cervical artery dissections, heart and brain, intracerebral haemorrhage, and acute stroke treatment. She has made her primary interest the treatment and prevention of stroke in women and working on stroke guidelines in women.




Posted on 7 March, 20185 March, 2021